These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization. He JJ, Yin XX, Wang T, Chen MY, Li XL, Yang XJ, Shao HY. J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313 [Abstract] [Full Text] [Related]
43. A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma. Fiorentini G, Sarti D, Carandina R, Mulazzani L, Mincarelli C, Candelari R, Argirò R, Fiorentini C, Aliberti C. Future Oncol; 2019 Mar; 15(7):695-703. PubMed ID: 30444424 [Abstract] [Full Text] [Related]
44. Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma. Sattler T, Bredt C, Surwald S, Rust C, Rieger J, Jakobs T. Anticancer Res; 2018 Feb; 38(2):1025-1032. PubMed ID: 29374736 [Abstract] [Full Text] [Related]
45. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma. Hoffmann R, Rempp H, Syha R, Ketelsen D, Pereira PL, Claussen CD, Clasen S. Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871 [Abstract] [Full Text] [Related]
46. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Lencioni R, Paolicchi A, Moretti M, Pinto F, Armillotta N, Di Giulio M, Cicorelli A, Donati F, Cioni D, Bartolozzi C. Eur Radiol; 1998 Oct; 8(3):439-44. PubMed ID: 9510580 [Abstract] [Full Text] [Related]
47. Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization. Chen S, Ji R, Shi X, Wang Z, Zhu D. Braz J Med Biol Res; 2019 Oct; 52(12):e8467. PubMed ID: 31800729 [Abstract] [Full Text] [Related]
48. Safety and efficacy of drug-eluting microspheres chemoembolization under cone beam computed tomography control in patients with early and intermediate stage hepatocellular carcinoma. Korsic S, Levasic N, Dezman R, Zupan LAL, Trotovsek B, Jansa R, Smid A, Popovic P. Radiol Oncol; 2022 Aug 14; 56(3):311-318. PubMed ID: 35535426 [Abstract] [Full Text] [Related]
50. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma. Urbano J, Echevarria-Uraga JJ, Ciampi-Dopazo JJ, Sánchez-Corral JA, Cobos Alonso J, Anton-Ladislao A, Peña-Baranda B, Nacarino-Mejias V, González-Costero R, Muñoz Ruiz-Canela JJ, Pérez-Cuesta J, Lanciego C, de Gregorio MA. Eur J Radiol; 2020 May 14; 126():108966. PubMed ID: 32278280 [Abstract] [Full Text] [Related]
51. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liu YS, Lin CY, Chuang MT, Lin CY, Tsai YS, Wang CK, Ou MC. BMC Gastroenterol; 2018 Aug 03; 18(1):124. PubMed ID: 30075752 [Abstract] [Full Text] [Related]
52. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G, Bargellini I, Petruzzi P, Massa Saluzzo C, Crespi S, Sarti I. Cardiovasc Intervent Radiol; 2008 Aug 03; 31(6):1141-9. PubMed ID: 18696150 [Abstract] [Full Text] [Related]
53. Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients. Zhou GH, Han J, Sun JH, Zhang YL, Zhou TY, Nie CH, Zhu TY, Chen SQ, Wang BQ, Yu ZN, Wang HL, Chen LM, Wang WL, Zheng SS. BMC Cancer; 2018 Jun 08; 18(1):644. PubMed ID: 29914435 [Abstract] [Full Text] [Related]
57. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety. Zhang ZS, Li HZ, Ma C, Xiao YD. BMC Cancer; 2019 Nov 29; 19(1):1162. PubMed ID: 31783814 [Abstract] [Full Text] [Related]
58. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT. Kloth C, Thaiss WM, Kärgel R, Grimmer R, Fritz J, Ioanoviciu SD, Ketelsen D, Nikolaou K, Horger M. Acad Radiol; 2017 Nov 29; 24(11):1352-1363. PubMed ID: 28652049 [Abstract] [Full Text] [Related]
59. Balloon-Assisted Chemoembolization Using a Micro-Balloon Catheter Alongside a Microcatheter for a Hepatocellular Carcinoma with a Prominent Arterioportal Shunt: A Case Report. Hoshiai S, Mori K, Ishiguro T, Konishi T, Uchikawa Y, Fukuda K, Minami M. Cardiovasc Intervent Radiol; 2017 Apr 29; 40(4):625-628. PubMed ID: 27987001 [Abstract] [Full Text] [Related]
60. Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study. Ishikawa T, Imai M, Owaki T, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T, Kudo M. Dig Dis; 2017 Apr 29; 35(6):598-601. PubMed ID: 29040993 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]